Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by joe9999on Apr 11, 2018 10:12am
219 Views
Post# 27865718

RE:Good news! PBI-4050 deal is completed in principle...

RE:Good news! PBI-4050 deal is completed in principle...
Biofinder wrote: .... details are still being worked out, preliminary has been inked, final details to be announced soon in NR.
 
How do I know this? the same way I knew (and previously posted) that pbi-4050 worked as a treatment for fibrosis a year in advance of Prometic actually announcing the same in their NR. 
 
All timelines delayed thanks to combination of management and FDA workings, numbers and projections still appear valid.
 
Still appears 2020 is the explosion year for Prometic.
 
It pays to be a reader and consumer of both scientific and business information.
 
EOM




This RUMOR is discussed since...  2015 ???

JUST RUMOR for now ...
I need quite more arguments to "buy it" ...

PS:  I'm LONG on PLI ...

Bullboard Posts